Annual CFF
-$34.30 M
-$3.23 M-10.41%
September 30, 2022
Summary
- As of February 10, 2025, VIVO annual cash flow from financing activities is -$34.30 million, with the most recent change of -$3.23 million (-10.41%) on September 30, 2022.
- During the last 3 years, VIVO annual CFF has fallen by -$49.22 million (-329.97%).
Performance
VIVO Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly CFF
-$472.00 K
-$2.11 M-128.80%
September 30, 2022
Summary
- As of February 10, 2025, VIVO quarterly cash flow from financing activities is -$472.00 thousand, with the most recent change of -$2.11 million (-128.80%) on September 30, 2022.
- Over the past year, VIVO quarterly CFF has increased by +$14.71 million (+96.89%).
Performance
VIVO Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
TTM CFF
-$34.30 M
+$14.71 M+30.02%
September 30, 2022
Summary
- As of February 10, 2025, VIVO TTM cash flow from financing activities is -$34.30 million, with the most recent change of +$14.71 million (+30.02%) on September 30, 2022.
- Over the past year, VIVO TTM CFF has dropped by -$3.23 million (-10.41%).
Performance
VIVO TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
VIVO Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -10.4% | +96.9% | -10.4% |
| 3 y3 years | -330.0% | -100.0% | -261.2% |
| 5 y5 years | -23.8% | +92.6% | -261.2% |
VIVO Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | +10.4% | at low | -128.8% | +5065.9% | +6.7% | +47.4% |
| 5 y | 5-year | -330.0% | at low | -100.9% | +5644.9% | -249.9% | +47.4% |
| alltime | all time | -226.1% | at low | -100.9% | +5644.9% | -213.3% | +47.4% |
Meridian Bioscience Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2022 | -$34.30 M(+10.4%) | -$472.00 K(-128.8%) | -$34.30 M(-30.0%) |
| Jun 2022 | - | $1.64 M(-106.7%) | -$49.02 M(-3.1%) |
| Mar 2022 | - | -$24.38 M(+119.9%) | -$50.57 M(+57.3%) |
| Dec 2021 | - | -$11.09 M(-27.0%) | -$32.16 M(+3.5%) |
| Sep 2021 | -$31.07 M(+773.5%) | -$15.18 M(<-9900.0%) | -$31.07 M(-26.6%) |
| Jun 2021 | - | $87.00 K(-101.5%) | -$42.33 M(-657.9%) |
| Mar 2021 | - | -$5.97 M(-40.3%) | $7.59 M(-156.0%) |
| Dec 2020 | - | -$10.00 M(-62.2%) | -$13.56 M(+281.1%) |
| Sep 2020 | -$3.56 M(-123.8%) | -$26.44 M(-152.9%) | -$3.56 M(-115.5%) |
| Jun 2020 | - | $50.00 M(-284.4%) | $22.88 M(>+9900.0%) |
| Mar 2020 | - | -$27.12 M(<-9900.0%) | $219.00 K(-99.0%) |
| Dec 2019 | - | $0.00(0.0%) | $21.28 M(+42.6%) |
| Sep 2019 | $14.92 M(-154.0%) | $0.00(-100.0%) | $14.92 M(+133.8%) |
| Jun 2019 | - | $27.34 M(-551.1%) | $6.38 M(-123.5%) |
| Mar 2019 | - | -$6.06 M(-4.7%) | -$27.19 M(-1.3%) |
| Dec 2018 | - | -$6.36 M(-25.5%) | -$27.54 M(-0.2%) |
| Sep 2018 | -$27.60 M(-0.4%) | -$8.54 M(+36.9%) | -$27.60 M(+8.4%) |
| Jun 2018 | - | -$6.24 M(-2.8%) | -$25.46 M(-0.6%) |
| Mar 2018 | - | -$6.41 M(+0.0%) | -$25.63 M(+1.5%) |
| Dec 2017 | - | -$6.41 M(+0.2%) | -$25.24 M(-8.9%) |
| Sep 2017 | -$27.71 M(-201.9%) | -$6.40 M(+0.0%) | -$27.71 M(-7.6%) |
| Jun 2017 | - | -$6.40 M(+6.3%) | -$30.01 M(-8.2%) |
| Mar 2017 | - | -$6.02 M(-32.2%) | -$32.70 M(-229.5%) |
| Dec 2016 | - | -$8.89 M(+2.2%) | $25.25 M(-7.2%) |
| Sep 2016 | $27.20 M(-188.5%) | -$8.70 M(-4.4%) | $27.20 M(-7.8%) |
| Jun 2016 | - | -$9.09 M(-117.5%) | $29.52 M(-2.5%) |
| Mar 2016 | - | $51.93 M(-848.6%) | $30.27 M(-201.4%) |
| Dec 2015 | - | -$6.94 M(+8.7%) | -$29.85 M(-2.9%) |
| Sep 2015 | -$30.74 M(-3.2%) | -$6.38 M(-23.5%) | -$30.74 M(-4.8%) |
| Jun 2015 | - | -$8.34 M(+1.9%) | -$32.28 M(+0.4%) |
| Mar 2015 | - | -$8.19 M(+4.5%) | -$32.14 M(+0.1%) |
| Dec 2014 | - | -$7.83 M(-1.1%) | -$32.12 M(+1.1%) |
| Sep 2014 | -$31.75 M(+11.0%) | -$7.92 M(-3.5%) | -$31.75 M(+2.3%) |
| Jun 2014 | - | -$8.21 M(+0.6%) | -$31.03 M(+1.3%) |
| Mar 2014 | - | -$8.16 M(+9.3%) | -$30.63 M(+40.5%) |
| Dec 2013 | - | -$7.47 M(+3.8%) | -$21.81 M(-23.8%) |
| Sep 2013 | -$28.60 M(-6.8%) | -$7.20 M(-7.8%) | -$28.60 M(-1.6%) |
| Jun 2013 | - | -$7.81 M(-1274.3%) | -$29.06 M(+0.5%) |
| Mar 2013 | - | $665.00 K(-104.7%) | -$28.92 M(-22.7%) |
| Dec 2012 | - | -$14.26 M(+86.3%) | -$37.40 M(+21.9%) |
| Sep 2012 | -$30.67 M(+11.5%) | -$7.66 M(-0.1%) | -$30.67 M(+6.4%) |
| Jun 2012 | - | -$7.67 M(-2.0%) | -$28.83 M(+2.0%) |
| Mar 2012 | - | -$7.82 M(+3.8%) | -$28.25 M(+0.6%) |
| Dec 2011 | - | -$7.53 M(+29.7%) | -$28.07 M(+2.0%) |
| Sep 2011 | -$27.52 M(-5.7%) | -$5.81 M(-18.1%) | -$27.52 M(-5.7%) |
| Jun 2011 | - | -$7.09 M(-7.2%) | -$29.18 M(-1.9%) |
| Mar 2011 | - | -$7.64 M(+9.5%) | -$29.75 M(+1.3%) |
| Dec 2010 | - | -$6.98 M(-6.5%) | -$29.38 M(+0.7%) |
| Sep 2010 | -$29.19 M(+18.5%) | -$7.47 M(-2.6%) | -$29.19 M(+4.0%) |
| Jun 2010 | - | -$7.67 M(+5.4%) | -$28.06 M(+5.1%) |
| Mar 2010 | - | -$7.27 M(+7.1%) | -$26.69 M(+2.9%) |
| Dec 2009 | - | -$6.79 M(+7.2%) | -$25.93 M(+5.2%) |
| Sep 2009 | -$24.64 M(+47.6%) | -$6.33 M(+0.5%) | -$24.64 M(+11.2%) |
| Jun 2009 | - | -$6.30 M(-3.1%) | -$22.15 M(+4.4%) |
| Mar 2009 | - | -$6.50 M(+18.4%) | -$21.22 M(+15.4%) |
| Dec 2008 | - | -$5.50 M(+42.8%) | -$18.39 M(+10.2%) |
| Sep 2008 | -$16.69 M(+25.6%) | -$3.85 M(-28.3%) | -$16.69 M(+0.2%) |
| Jun 2008 | - | -$5.37 M(+45.9%) | -$16.66 M(+11.8%) |
| Mar 2008 | - | -$3.68 M(-3.0%) | -$14.91 M(-0.6%) |
| Dec 2007 | - | -$3.79 M(-0.6%) | -$14.99 M(+12.8%) |
| Sep 2007 | -$13.29 M(+30.0%) | -$3.82 M(+5.6%) | -$13.29 M(+10.9%) |
| Jun 2007 | - | -$3.62 M(-3.9%) | -$11.98 M(+5.6%) |
| Mar 2007 | - | -$3.76 M(+79.8%) | -$11.35 M(+7.2%) |
| Dec 2006 | - | -$2.09 M(-16.7%) | -$10.58 M(+3.5%) |
| Sep 2006 | -$10.22 M | -$2.51 M(-15.6%) | -$10.22 M(-166.2%) |
| Jun 2006 | - | -$2.98 M(-0.8%) | $15.45 M(+6.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2006 | - | -$3.00 M(+73.0%) | $14.55 M(-31.7%) |
| Dec 2005 | - | -$1.74 M(-107.5%) | $21.30 M(-5.8%) |
| Sep 2005 | $22.62 M(-330.2%) | $23.16 M(-697.2%) | $22.62 M(-691.3%) |
| Jun 2005 | - | -$3.88 M(-203.5%) | -$3.83 M(+3.1%) |
| Mar 2005 | - | $3.75 M(-1007.5%) | -$3.71 M(-53.9%) |
| Dec 2004 | - | -$413.00 K(-87.4%) | -$8.04 M(-18.1%) |
| Sep 2004 | -$9.83 M(0.0%) | -$3.28 M(-12.8%) | -$9.83 M(+18.9%) |
| Jun 2004 | - | -$3.76 M(+539.8%) | -$8.26 M(+7.1%) |
| Mar 2004 | - | -$588.00 K(-73.2%) | -$7.71 M(-3.1%) |
| Dec 2003 | - | -$2.19 M(+27.8%) | -$7.96 M(-19.0%) |
| Sep 2003 | -$9.83 M(+9.2%) | -$1.72 M(-46.6%) | -$9.83 M(-17.6%) |
| Jun 2003 | - | -$3.21 M(+286.4%) | -$11.93 M(+3.4%) |
| Mar 2003 | - | -$832.00 K(-79.5%) | -$11.54 M(+3.0%) |
| Dec 2002 | - | -$4.06 M(+6.4%) | -$11.20 M(+24.5%) |
| Sep 2002 | -$9.00 M(+27.7%) | -$3.82 M(+35.5%) | -$9.00 M(+42.0%) |
| Jun 2002 | - | -$2.82 M(+464.0%) | -$6.34 M(-6.1%) |
| Mar 2002 | - | -$500.00 K(-73.1%) | -$6.75 M(-15.4%) |
| Dec 2001 | - | -$1.86 M(+60.3%) | -$7.98 M(+13.3%) |
| Sep 2001 | -$7.05 M(-301.5%) | -$1.16 M(-64.1%) | -$7.05 M(-444.5%) |
| Jun 2001 | - | -$3.23 M(+86.8%) | $2.04 M(-645.3%) |
| Mar 2001 | - | -$1.73 M(+87.7%) | -$375.00 K(+66.7%) |
| Dec 2000 | - | -$922.00 K(-111.6%) | -$225.00 K(-106.4%) |
| Sep 2000 | $3.50 M(-187.4%) | $7.93 M(-240.3%) | $3.50 M(-166.5%) |
| Jun 2000 | - | -$5.65 M(+257.6%) | -$5.26 M(+1279.5%) |
| Mar 2000 | - | -$1.58 M(-156.5%) | -$381.00 K(-227.0%) |
| Dec 1999 | - | $2.80 M(-440.6%) | $300.00 K(-107.5%) |
| Sep 1999 | -$4.00 M(+21.2%) | -$822.00 K(+5.7%) | -$4.00 M(-1.9%) |
| Jun 1999 | - | -$778.00 K(-13.6%) | -$4.08 M(+1.9%) |
| Mar 1999 | - | -$900.00 K(-40.0%) | -$4.00 M(+2.6%) |
| Dec 1998 | - | -$1.50 M(+66.7%) | -$3.90 M(+18.2%) |
| Sep 1998 | -$3.30 M(+17.9%) | -$900.00 K(+28.6%) | -$3.30 M(+10.0%) |
| Jun 1998 | - | -$700.00 K(-12.5%) | -$3.00 M(+3.4%) |
| Mar 1998 | - | -$800.00 K(-11.1%) | -$2.90 M(+7.4%) |
| Dec 1997 | - | -$900.00 K(+50.0%) | -$2.70 M(-3.6%) |
| Sep 1997 | -$2.80 M(-120.4%) | -$600.00 K(0.0%) | -$2.80 M(-130.1%) |
| Jun 1997 | - | -$600.00 K(0.0%) | $9.30 M(-30.6%) |
| Mar 1997 | - | -$600.00 K(-40.0%) | $13.40 M(0.0%) |
| Dec 1996 | - | -$1.00 M(-108.7%) | $13.40 M(-2.2%) |
| Sep 1996 | $13.70 M(-4666.7%) | $11.50 M(+228.6%) | $13.70 M(+756.3%) |
| Jun 1996 | - | $3.50 M(-683.3%) | $1.60 M(-188.9%) |
| Mar 1996 | - | -$600.00 K(-14.3%) | -$1.80 M(+80.0%) |
| Dec 1995 | - | -$700.00 K(+16.7%) | -$1.00 M(+233.3%) |
| Sep 1995 | -$300.00 K(-57.1%) | -$600.00 K(-700.0%) | -$300.00 K(<-9900.0%) |
| Jun 1995 | - | $100.00 K(-50.0%) | $0.00(0.0%) |
| Mar 1995 | - | $200.00 K(>+9900.0%) | $0.00(-100.0%) |
| Dec 1994 | - | $0.00(-100.0%) | -$400.00 K(-42.9%) |
| Sep 1994 | -$700.00 K(-107.1%) | -$300.00 K(-400.0%) | -$700.00 K(-109.7%) |
| Jun 1994 | - | $100.00 K(-150.0%) | $7.20 M(-27.3%) |
| Mar 1994 | - | -$200.00 K(-33.3%) | $9.90 M(+2.1%) |
| Dec 1993 | - | -$300.00 K(-103.9%) | $9.70 M(-1.0%) |
| Sep 1993 | $9.80 M(+880.0%) | $7.60 M(+171.4%) | $9.80 M(+366.7%) |
| Jun 1993 | - | $2.80 M(-800.0%) | $2.10 M(-362.5%) |
| Mar 1993 | - | -$400.00 K(+100.0%) | -$800.00 K(-188.9%) |
| Dec 1992 | - | -$200.00 K(+100.0%) | $900.00 K(-10.0%) |
| Sep 1992 | $1.00 M(-266.7%) | -$100.00 K(0.0%) | $1.00 M(0.0%) |
| Jun 1992 | - | -$100.00 K(-107.7%) | $1.00 M(0.0%) |
| Mar 1992 | - | $1.30 M(-1400.0%) | $1.00 M(-350.0%) |
| Dec 1991 | - | -$100.00 K(0.0%) | -$400.00 K(-33.3%) |
| Sep 1991 | -$600.00 K(+500.0%) | -$100.00 K(0.0%) | -$600.00 K(0.0%) |
| Jun 1991 | - | -$100.00 K(0.0%) | -$600.00 K(+20.0%) |
| Mar 1991 | - | -$100.00 K(-66.7%) | -$500.00 K(+25.0%) |
| Dec 1990 | - | -$300.00 K(+200.0%) | -$400.00 K(+300.0%) |
| Sep 1990 | -$100.00 K | -$100.00 K(<-9900.0%) | -$100.00 K(<-9900.0%) |
| Jun 1990 | - | $0.00(0.0%) | $0.00(0.0%) |
| Mar 1990 | - | $0.00(0.0%) | $0.00(0.0%) |
| Dec 1989 | - | $0.00 | $0.00 |
FAQ
- What is Meridian Bioscience annual cash flow from financing activities?
- What is the all time high annual CFF for Meridian Bioscience?
- What is Meridian Bioscience annual CFF year-on-year change?
- What is Meridian Bioscience quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Meridian Bioscience?
- What is Meridian Bioscience quarterly CFF year-on-year change?
- What is Meridian Bioscience TTM cash flow from financing activities?
- What is the all time high TTM CFF for Meridian Bioscience?
- What is Meridian Bioscience TTM CFF year-on-year change?
What is Meridian Bioscience annual cash flow from financing activities?
The current annual CFF of VIVO is -$34.30 M
What is the all time high annual CFF for Meridian Bioscience?
Meridian Bioscience all-time high annual cash flow from financing activities is $27.20 M
What is Meridian Bioscience annual CFF year-on-year change?
Over the past year, VIVO annual cash flow from financing activities has changed by -$3.23 M (-10.41%)
What is Meridian Bioscience quarterly cash flow from financing activities?
The current quarterly CFF of VIVO is -$472.00 K
What is the all time high quarterly CFF for Meridian Bioscience?
Meridian Bioscience all-time high quarterly cash flow from financing activities is $51.93 M
What is Meridian Bioscience quarterly CFF year-on-year change?
Over the past year, VIVO quarterly cash flow from financing activities has changed by +$14.71 M (+96.89%)
What is Meridian Bioscience TTM cash flow from financing activities?
The current TTM CFF of VIVO is -$34.30 M
What is the all time high TTM CFF for Meridian Bioscience?
Meridian Bioscience all-time high TTM cash flow from financing activities is $30.27 M
What is Meridian Bioscience TTM CFF year-on-year change?
Over the past year, VIVO TTM cash flow from financing activities has changed by -$3.23 M (-10.41%)